The Computational Science Group of GRIB led by Gianni de Fabritiis is involved on this project and will have a central role regarding research on biomedical science, both with simulation methods and deep learning based applications. The group will also be working towards integrating results from modelling and simulation data with clinical and/or experimental data, supporting the combination of high-throughput data analytics with HPC based results, which will provide users a way to leverage the results produced by CompBioMed's research.

CompBioMed project started on 2016 and has been extended on October 2019 for another 4 years, until 2023. The Project is a European Commission H2020 funded Centre of Excellence focussed on the use and development of computational methods for biomedical applications. It has users within academia, industry and clinical environments and is working to train more people in the use of its products and methods. To celebrate the extension and to discuss matters arising from the new project, a Kick-Off meeting was held in Garching, near Munich, Germany on 21-23 October 2019. In this meeting, a particular focus of attention was on machine learning (high performance data analytics) and its interaction with mechanistic modelling and simulation on high performance computers, our preparedness for the advent of exascale computers, innovation and the expansion of our education and training programmes. That was coupled with a lecture by partners Atos and LRZ on their work to introduce and integrate Quantum Computers into their business which will take place in October.

Read more about the project at https://www.compbiomed.eu/

Read more about other projects of the Computational Science Group of GRIB

Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream